Senseonics Q3 revenue $4.3M, gross loss $4.1M; Eversense 365 launch underway

Senseonics Holdings, Inc.

2024-Q3 EPS reported -$0.10 revenue$14,175,000

Total revenue $4.3M, down ~30% YoY from $6.1M; U.S. revenue $2.4M vs $3.9M.
Gross loss $4.1M vs gross profit $1.2M, driven by $4.8M one-time charges for Eversense 365 transition.
Net loss $24.0M ($0.04/share), essentially flat vs $24.1M in Q3 2023.
Cash $74.8M, debt $55.9M; raised $16M post-quarter; FY2024 revenue guidance ~$22M.
FDA approved Eversense 365 (365-day CGM); first commercial insertion at Mercy; restructuring targets $10M cash OPEX cut in 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.